GenFleet Therapeutics (Shanghai) Inc.
GenFleet Therapeutics (Shanghai) Inc. (HKSE: 2595) is trading at HK$29.62, about ₹363 at today's HKD/INR rate, as of 29 Sep 2026, 1:15 AM ET, up 8.10% today. Indian residents can buy GenFleet Therapeutics (Shanghai) from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$27.54
Today's high
HK$29.64
52 week low
HK$19.60
52 week high
HK$52.90
2595 opened at HK$27.56, closed previously at HK$27.40, and has traded between HK$19.60 and HK$52.90 over the past 52 weeks.
About
GenFleet Therapeutics (Shanghai) Inc., a biopharmaceutical company, develops treatment options in the fields of oncology, autoimmune, and inflammatory diseases in the United States. The company develops GFH375, an orally bioavailable small molecule inhibitor of Kirsten rat sarcoma (KRAS) G12C in a Phase III trial for the treatment of pancreatic cancer, as well as in Phase II trials for the treatment of non-small cell lung cancer (NSCLC) and BTC, and in a Phase I trial for the treatment of solid tumors; GFH925, a small molecule selective inhibitor of KRAS G12C in a Phase II trial for the treatment of advanced NSCLC; and GFH009, a highly selective cyclin-dependent kinase (CDK) 9 inhibitor in a Phase II trial for the treatment of AML. It is also developing GFH276, a pan-RAS inhibitor in a Phase I trial for the treatment of solid tumors; GFS202A, a bispecific antibody in a Phase I trial for the treatment of cachexia; GFH312, a receptor-interacting serine/threonine-protein kinase (RIPK) 1 inhibitor in a Phase I clinical trial for the treatment of PAD with IC and PBC; GFS784, a pan-RAS antibody drug conjugate (ADC) candidate with an IND application for the treatment of solid tumors; and GFH946, an oral PROTAC product candidate with an IND application for the treatment of type 2 inflammation. In addition, the company offers technical services. It has collaboration agreements with Merck Healthcare KGaA for trials of combinational regimens, including cetuximab; Verastem, Inc. to develop and commercialize GFH375; and SELLAS Life Sciences Group, Inc. to develop, manufacture, and commercialize GFH009. GenFleet Therapeutics (Shanghai) Inc. was incorporated in 2017 and is headquartered in Shanghai, China.
Key statistics
Avg. volume
2.38M
Market cap
HK$10.42B
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
1.02
Dividend yield
—
Last dividend
HK$0.00
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
—
Gross margin
—
EBITDA
—
Revenue growth
—
How to buy GenFleet Therapeutics (Shanghai) from India
Indian residents can buy GenFleet Therapeutics (Shanghai) shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for GenFleet Therapeutics (Shanghai) and place an order
Find GenFleet Therapeutics (Shanghai) by name or by its ticker, 2595, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. GenFleet Therapeutics (Shanghai) trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your GenFleet Therapeutics (Shanghai) position in HKD and INR. GenFleet Therapeutics (Shanghai) pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in GenFleet Therapeutics (Shanghai) from India
Trading and taxes when buying GenFleet Therapeutics (Shanghai) from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneGenFleet Therapeutics (Shanghai) does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy GenFleet Therapeutics (Shanghai) stock?
Yes. GenFleet Therapeutics (Shanghai) (2595) has been listed on the Hong Kong Stock Exchange since 2025, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one GenFleet Therapeutics (Shanghai) share cost in rupees?
One GenFleet Therapeutics (Shanghai) share is HK$29.62 — about ₹363 at an HKD/INR rate of 12.25 on 28 Sep 2026. Both the GenFleet Therapeutics (Shanghai) price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying GenFleet Therapeutics (Shanghai) from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of GenFleet Therapeutics (Shanghai)?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on GenFleet Therapeutics (Shanghai) shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the GenFleet Therapeutics (Shanghai) price. Paasa issues a capital-gains statement for your return.
Does GenFleet Therapeutics (Shanghai) pay a dividend?
No. GenFleet Therapeutics (Shanghai) does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade GenFleet Therapeutics (Shanghai) from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is GenFleet Therapeutics (Shanghai) a Hong Kong SAR China company, and does that change how it is taxed?
GenFleet Therapeutics (Shanghai) trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. GenFleet Therapeutics (Shanghai) trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare GenFleet Therapeutics (Shanghai) shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your GenFleet Therapeutics (Shanghai) holding, its cost and its closing value.
How do I sell GenFleet Therapeutics (Shanghai) and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.